Zora Novakova

Title: Zora Novakova: Innovator in Monoclonal Antibody Development

Introduction

Zora Novakova is a prominent inventor based in Vestec, Czech Republic. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on creating innovative solutions for cancer treatment, specifically targeting prostate cancer.

Latest Patents

Zora Novakova holds a patent for the "Development of new monoclonal antibodies recognizing human prostate-specific membrane antigen (PSMA)." This patent describes compositions and methods that include isolated antibodies capable of recognizing PSMA. These antibodies have potential applications in imaging and therapy for PSMA-expressing cancers, such as prostate cancer.

Career Highlights

Throughout her career, Zora has worked with esteemed institutions, including The Johns Hopkins University and the Institute of Biotechnology CAS, v.v.i. Her experience in these organizations has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Zora has collaborated with notable professionals in her field, including Cyril Barinka and Martin Gilbert Pomper. These partnerships have enhanced her research efforts and expanded the impact of her work.

Conclusion

Zora Novakova is a trailblazer in the development of monoclonal antibodies, with a focus on improving cancer treatment. Her innovative research and collaborations continue to make a significant impact in the field of biotechnology.